This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsDividendOwnershipTrendsBuy This Stock KOOL vs. THMO, IVVD, SPRO, BMEA, RCEL, SEER, CRBP, CNTB, QIPT, and MGNXShould you be buying Cesca Therapeutics stock or one of its competitors? The main competitors of Cesca Therapeutics include ThermoGenesis (THMO), Invivyd (IVVD), Spero Therapeutics (SPRO), Biomea Fusion (BMEA), Avita Medical (RCEL), Seer (SEER), Corbus Pharmaceuticals (CRBP), Connect Biopharma (CNTB), Quipt Home Medical (QIPT), and MacroGenics (MGNX). These companies are all part of the "medical" sector. Cesca Therapeutics vs. Its Competitors ThermoGenesis Invivyd Spero Therapeutics Biomea Fusion Avita Medical Seer Corbus Pharmaceuticals Connect Biopharma Quipt Home Medical MacroGenics Cesca Therapeutics (NASDAQ:KOOL) and ThermoGenesis (NASDAQ:THMO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends. Do institutionals & insiders believe in KOOL or THMO? 3.1% of Cesca Therapeutics shares are owned by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are owned by institutional investors. 68.9% of Cesca Therapeutics shares are owned by company insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, KOOL or THMO? Cesca Therapeutics has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Does the media refer more to KOOL or THMO? In the previous week, Cesca Therapeutics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score. Company Overall Sentiment Cesca Therapeutics Neutral ThermoGenesis Neutral Which has higher valuation and earnings, KOOL or THMO? ThermoGenesis has lower revenue, but higher earnings than Cesca Therapeutics. Cesca Therapeutics is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCesca Therapeutics$9.67M3.10-$39.72M-$3.60-3.45ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A Is KOOL or THMO more profitable? ThermoGenesis has a net margin of 0.00% compared to Cesca Therapeutics' net margin of -98.84%. ThermoGenesis' return on equity of 0.00% beat Cesca Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cesca Therapeutics-98.84% -77.30% -37.75% ThermoGenesis N/A N/A N/A SummaryThermoGenesis beats Cesca Therapeutics on 8 of the 10 factors compared between the two stocks. Get Cesca Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KOOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOOL vs. The Competition Export to ExcelMetricCesca TherapeuticsLaboratory Apparatus & Furniture IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.98M$1K$5.78B$10.18BDividend Yield0.50%N/A5.73%4.60%P/E Ratio-3.45N/A75.5626.02Price / Sales3.100.00461.6291.38Price / CashN/AN/A25.8129.91Price / Book3.99N/A12.726.25Net Income-$39.72M-$17.98M$3.29B$270.76M Cesca Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KOOLCesca TherapeuticsN/A$12.41-0.8%N/A+17.0%$29.98M$9.67M-3.4553THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040IVVDInvivyd3.4189 of 5 stars$1.03+5.9%$3.18+209.1%+24.3%$116.90M$25.38M-1.12100Short Interest ↑SPROSpero Therapeutics4.386 of 5 stars$2.05-1.0%$5.00+143.9%+38.7%$116.49M$47.98M-2.09150News CoverageShort Interest ↓BMEABiomea Fusion3.4355 of 5 stars$2.03+4.1%$14.80+629.1%-75.4%$116.04MN/A-0.6750Positive NewsRCELAvita Medical2.3018 of 5 stars$4.29-1.2%$12.40+189.0%-55.6%$115.53M$64.25M-2.18130SEERSeer0.7107 of 5 stars$2.04-0.5%N/A+21.3%$115.50M$14.17M-1.47160CRBPCorbus Pharmaceuticals4.3209 of 5 stars$9.74+3.9%$49.00+403.1%-83.0%$114.83MN/A-2.0540Positive NewsCNTBConnect Biopharma3.7235 of 5 stars$2.11+2.4%$7.00+231.8%+26.8%$114.79M$26.03M0.00110News CoverageShort Interest ↓Analyst RevisionQIPTQuipt Home Medical1.9039 of 5 stars$2.59-1.5%$3.15+21.6%-4.6%$114.26M$245.91M-10.791,200MGNXMacroGenics4.4429 of 5 stars$1.74-1.7%$3.60+106.9%-57.0%$111.87M$149.96M-3.05430High Trading Volume Related Companies and Tools Related Companies THMO Alternatives IVVD Alternatives SPRO Alternatives BMEA Alternatives RCEL Alternatives SEER Alternatives CRBP Alternatives CNTB Alternatives QIPT Alternatives MGNX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KOOL) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
